100 East Carroll Avenue, Salisbury, MD, 21801 · (410) 546-6400
Beds
275
FY 2025
Star rating
4 of 5
Patient survey: 3 of 5
Net patient revenue
$567.2M
FY 2025
Net income
$68.4M
Patient care margin -2.5%
Discharges
15,984
Occupancy 80.5%
Clinicians
935
From the hospital's yearly cost reports (fiscal years as the hospital reports them)
Locations are shown at the center of the ZIP code.
US dollars as reported. Patient care margin = net patient revenue minus operating expenses, before other income such as grants, donations and investments.
| Fiscal year | Net patient revenue | Operating expenses | Patient care margin | Net income | Discharges | Uncompensated care | Medicare days | Medicaid days |
|---|---|---|---|---|---|---|---|---|
| 2025 | $567.2M | $581.0M | -2.5% | $68.4M | 15,984 | $18.1M | 35.9% | 5.6% |
Official hospital quality measures with the national median across hospitals. For ratios, 1.00 means as many cases as expected.
| Death rate after heart bypass surgery | 3.3% | US median 2.3% |
| Death rate for COPD patients | 13% | US median 8.5% |
| Death rate for heart attack patients | 11.4% | US median 11.8% |
| Death rate for heart failure patients | 10.5% | US median 11% |
| Hospital-wide death rate within 30 days | 3.2% | US median 3.9% |
| Death rate for pneumonia patients | 17.7% | US median 15.2% |
| Death rate for stroke patients |
Medicare clinicians who list this hospital, by specialty
Inpatient stays by diagnosis related group (DRG), 2024
Official US government data: hospital records, ownership records, yearly cost reports and quality measures, linked by the hospital's CCN and NPI. Financials are for fiscal years as reported by the hospital.
Medicare clinicians who work here
| 2024 | $539.6M | $502.2M | 6.9% | $91.8M | 15,757 | $8.9M | 42.7% | 6.3% |
| 2023 | $493.4M | $489.5M | 0.8% | $45.8M | 13,745 | $11.7M | 50.7% | 6.3% |
| 2022 | $472.1M | $454.2M | 3.8% | -$42.6M | 12,686 | $14.4M | 52.9% | 6.4% |
| 2021 | $471.6M | $433.0M | 8.2% | $149.5M | 11,592 | $12.6M | 54.2% | 5.8% |
| 2020 | $463.9M | $493.3M | -6.3% | $26.4M | 12,374 | $13.4M | 48.9% | 5.0% |
| 10.5% |
| US median 11.6% |
| Readmission rate after heart bypass surgery | 11.7% | US median 10.9% |
| Readmission rate for COPD | 18.8% | US median 19.8% |
| Readmission rate after a heart attack | 14.7% | US median 14.4% |
| Readmission rate for heart failure | 18.6% | US median 21.3% |
| Readmission rate after hip or knee replacement | 5.8% | US median 5.8% |
| Readmission rate for pneumonia | 16.9% | US median 17.2% |
| Complications after hip or knee replacement | 4.6% | US median 4.1% |
| Serious complications (patient safety composite) | 0.91 | US median 0.96 |
| C. diff intestinal infections (ratio to expected) | 0.31 | US median 0.28 · better |
| Central line bloodstream infections (ratio to expected) | 0.28 | US median 0.48 · better |
| Surgical site infections after colon surgery (ratio to expected) | 0.84 | US median 0.72 |
| MRSA bloodstream infections (ratio to expected) | 0.79 | US median 0.60 |
| Catheter urinary tract infections (ratio to expected) | 0.96 | US median 0.40 |
| Doctors always communicated well | 74% | US median 79% |
| Nurses always communicated well | 78% | US median 80% |
| Patient survey summary star rating | 3 of 5 | US median 3 of 5 |
| Area around the room always quiet at night | 46% | US median 59% |
| Patients who rated the hospital 9 or 10 out of 10 | 67% | US median 72% |
| Room and bathroom always clean | 64% | US median 73% |
| Patients who would definitely recommend the hospital | 66% | US median 71% |
| Patients who left the emergency department before being seen | 3% | US median 1% |
| Median time in the emergency department before leaving (minutes) | 177 min | US median 148 min |
| Patients prescribed 2 or more opioids or opioids with benzodiazepines at discharge | 13% | US median 15% |
| Patients who got appropriate care for severe sepsis and septic shock | 57% | US median 65% |
| Healthcare workers given the flu vaccine | 94% | US median 79% |
| Stroke patients who got a brain scan within 45 minutes of arrival | 69% | US median 74% |
| 223 |
| $17,713.53 |
| $14,470.63 |
| $9,973.97 |
| DRG 872 SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MCC | 183 | $15,575.19 | $12,426.67 | $7,681.44 |
| DRG 274 PERCUTANEOUS AND OTHER INTRACARDIAC PROCEDURES WITHOUT MCC | 124 | $47,617.78 | $40,550.85 | $24,748.54 |
| DRG 065 INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH CC OR TPA IN 24 HOURS | 102 | $13,157.63 | $10,356.78 | $7,474.08 |
| DRG 885 PSYCHOSES | 96 | $14,480.58 | $11,784.14 | $11,869.17 |
| DRG 683 RENAL FAILURE WITH CC | 94 | $14,371.35 | $11,489.23 | $6,629.69 |
| DRG 853 INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURES WITH MCC | 85 | $48,846.47 | $41,424.81 | $40,556.82 |
| DRG 267 ENDOVASCULAR CARDIAC VALVE REPLACEMENT AND SUPPLEMENT PROCEDURES WITHOUT MCC | 84 | $71,660.56 | $61,321.44 | $40,566.75 |
| DRG 177 RESPIRATORY INFECTIONS AND INFLAMMATIONS WITH MCC | 81 | $19,078.20 | $15,889.85 | $12,667.88 |
| DRG 322 PERCUTANEOUS CARDIOVASCULAR PROCEDURES WITH INTRALUMINAL DEVICE WITHOUT MCC | 77 | $16,166.65 | $12,259.81 | $12,904.99 |
| DRG 378 GASTROINTESTINAL HEMORRHAGE WITH CC | 76 | $15,913.12 | $13,042.84 | $7,294.77 |
| DRG 392 ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MCC | 71 | $14,314.18 | $11,512.42 | $5,662.18 |
| DRG 193 SIMPLE PNEUMONIA AND PLEURISY WITH MCC | 71 | $14,260.62 | $11,472.63 | $9,867.73 |
Reported payments to this teaching hospital
| Company | Payments | Amount |
|---|---|---|
| Janssen Research & Development, LLC JNJ | 27 | $208K |
| Amgen Inc. AMGN | 2 | $100K |
| CathWorks, Inc. | 4 | $25K |
| Medtronic, Inc. MDT | 16 | $10K |
| Genentech, Inc. ROG.SW | 3 | $4,750 |
| Aesculap, Inc. | 1 | $3,516 |
| Stryker Corporation SYK | 2 | $628 |
| Linvatec Corporation CNMD | 1 | $484 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $300 |
| Sterilmed, Inc. | 1 | $82.13 |
Official US government data on Original Medicare hospital stays and outpatient services; groups with fewer than 11 cases are not published. Payments are those drug and device companies must report.
Tidalhealth Peninsula Regional, Inc is a nonprofit short-term acute care hospital in Salisbury, MD with 275 beds, part of TidalHealth Peninsula Regional and a 4-star overall rating.
Tidalhealth Peninsula Regional, Inc in Salisbury, MD has 275 beds (fiscal year 2025 cost report); 362 beds are certified for Medicare. It discharged 15,984 inpatients that year, with 80.5% of its beds in use on average.
In fiscal year 2025 (ending 2025-06-30), Tidalhealth Peninsula Regional, Inc reported net patient revenue of $567.2M and operating expenses of $581.0M, a margin on patient care of -2.5%. After other income and expenses its net income was $68.4M (10.5% of revenue), so it made a profit that year.
Tidalhealth Peninsula Regional, Inc is part of TidalHealth Peninsula Regional, a health system with 2 hospitals based in Salisbury, MD. It is a nonprofit hospital.
Tidalhealth Peninsula Regional, Inc has an overall rating of 4 out of 5 stars in the official hospital quality ratings. Patients rate it 3 out of 5 stars in the patient survey. 0 death rate measures are better and 1 worse than the national rate.
Yes, Tidalhealth Peninsula Regional, Inc provides emergency services.
935 Medicare clinicians list Tidalhealth Peninsula Regional, Inc as a hospital they work at, most often in Nurse Practitioner, Physician Assistant, Internal Medicine.
In 2024, Tidalhealth Peninsula Regional, Inc had 5,064 Medicare inpatient stays in 128 diagnosis groups. The most common was DRG 871 (septicemia or severe sepsis without mv >96 hours with mcc) with 632 stays; Medicare paid $18,013.91 per stay on average, compared with $15,524.21 across all hospitals.
In 2025, companies reported $353K in payments to Tidalhealth Peninsula Regional, Inc as a teaching hospital ($5,021 general and $348K for research) from 11 companies.